Jan Orwar

Jan Orwar

Directeur/Bestuurslid bij FLUICELL AB
62 jaar
Consumer Services
Commercial Services
Health Technology

Profiel

Jan Owe Owesson Orwar was the founder of Cellectricon AB, founded in 2000, where the title held was Director & Chief Scientific Officer.
Dr. Orwar is the founder of Nanoxis AB, founded in 2002, where the title held was Director & Chief Scientific Advisor from 2002 to 2014.
Dr. Orwar is also the founder of Oblique Therapeutics AB. Dr. Orwar is currently Director-Bioeletronics & Bio-Computing Program at Chalmers University of Technology since 2011.
Dr. Orwar is currently Director at Fluicell AB since 2015.
Dr. Orwar is currently Senior Group Leader at Karolinska Institutet.
Former positions include President-Research & Development at Piramal Enterprises Ltd. and Global Vice President-Research & Development at Sanofi AB. Education includes doctorates from Stanford University and the University of Gothenburg.

Actieve functies van Jan Orwar

BedrijvenFunctieBegin
FLUICELL AB Directeur/Bestuurslid 01-01-2015
Corporate Officer/Principal 17-01-2011
Corporate Officer/Principal -

Eerdere bekende functies van Jan Orwar

BedrijvenFunctieEinde
Oprichter 11-02-2014
PIRML ENT Hoofd Techniek/Wetenschap/O&O -
Hoofd Techniek/Wetenschap/O&O -
Algemeen Directeur -
Oprichter -
Ervaring van Jan Orwar in detail bekijken

Opleiding van Jan Orwar

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

84

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit10

Commercial Services

Consumer Services

Finance

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Distribution Services

Health Technology

  1. Beurs
  2. Insiders
  3. Jan Orwar